The treatment of primary and metastatic hepatic neoplasms using percutaneous cryotherapy

Seminars in Interventional Radiology

Volumn 23, Issue 1, 2006, Pages 39-46

  Smith, Mitchell T ^b   Ray Jr , Charles E ^a,b  

^a DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Ablation; Cryotherapy; Liver malignancy

Indexed keywords

ALCOHOL; ANTHRACYCLINE DERIVATIVE; ARGON; BEVACIZUMAB; CETUXIMAB; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; ICE; IRINOTECAN; NITROGEN; OXALIPLATIN; STREPTOZOCIN;

CANCER CHEMOTHERAPY; CANCER SURGERY; CELL DEATH; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; DEHYDRATION; DRUG EFFECT; EXTRACELLULAR SPACE; FREEZING; HUMAN; INTRACELLULAR SPACE; INVASIVE PROCEDURE; LAPAROSCOPY; LAPAROTOMY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; MICROANGIOPATHY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE ECHOGRAPHY; PROTEIN DENATURATION; RADIOFREQUENCY ABLATION; REVIEW; ULTRASOUND;

EID: 33646098402     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-939840     Document Type: Review

References (81)

1. Staley CA. Surgical therapy of hepatic tumors. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. Philadelphia: Saunders; 2003:1371-1381
2. Scheele J. Hepatectomy for liver metastases. Br J Surg 1993;80:274-276
3. Gilbert HA, Kagan AR. Metastases: incidence, detection and evaluation without histologic confirmation. In: Weiss L, ed. Fundamental Aspects of Metastases. Amsterdam: North Holland Publishing; 1976:385-405
4. Geoghegan JG, Scheele J. Treatment of colorectal liver metastasis. Br J Surg 1999;86:158-169
5. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994;344:1255-1260
6. Goldberg SN, Ahmed M. Minimally invasive image-guided therapies for hepatocellular carcinoma. J Clin Gastroenterol 2002;35:S115-S129
7. Ravikumar TS, Steele GD Jr. Hepatic cryosurgery. Surg Clin North Am 1989;69:433-440
8. McCarthy T, Kuhn JA. Cryotherapy for liver tumors. Oncology 1998;12:979-993
9. Cuschieri A, Crosthwaite G, Shimi S, et al. Hepatic cryotherapy for liver tumors: development and clinical evaluation of a high-efficiency insulated multineedle probe system for open and laparoscopic use. Surg Endosc 1995;9:483-489
10. Adam R, Majno P, Castaing D, et al. Treatment of irresectable liver tumors by percutaneous cryosurgery. Br J Surg 1998;85:1493-1494
11. Frezza EE. Therapeutic management algorithm in cirrhotic and noncirrhotic patients in primary or secondary liver masses. Dig Dis Sci 2004;49:866-871
12. Farmer DG, Rosove MH, Shaked A, et al. Current treatment modalities for HCC. Ann Surg 1994;219:236-247
13. Zibari GB, Riche A, Zizzi HC, et al. Surgical and non-surgical management of primary and metastatic liver tumors. Am Surg 1998;64:211-220
14. Nagasue N, Yukay H, Ogawa Y, et al. Clinical experience with 118 hepatic resections for HCC. Surgery 1986;99:694-701
15. Wu M, Chen H, Yao X. Surgical treatment of primary liver cancer. Zhonghua Wai Ke Za Zhi 1996;34:707-710
16. Moreno Gonzalez E, Gomez R, Garcia I, et al. Liver transplantation in malignant hepatic neoplasms. Am J Surg 1992;163:395-400
17. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small HCC in patients with cirrhosis. N Engl J Med 1996;334:693-699
18. Pichlmayr R, Weimann A, Oldhafer KJ, et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 1995;19:807-813
19. Selby R, Kadry Z, Carr B, et al. Liver transplantation for HCC. World J Surg 1995;19:53-58
20. Gugenheim J, Baldini E, Casaccia M, et al. Hepatic resection and transplantation for HCC in patients with cirrhosis. Gastroenterol Clin Biol 1997;21:590-595
21. Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg 1999;86:158-169
22. Holbrook RF, Koo K, Ryan JA. Resection of malignant primary liver tumors. Am J Surg 1996;171:453-455
23. Huscher CGS, Lirici MM, Crafa F, Corradi A, Recher A. The technique of laparoscopic liver resection. 7th World Congress of Endoscopic Surgery, Singapore, 2000:497-506
24. Nerenstone SR, Ihde DC, Friedman MA. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev 1988;15:1-31
25. Colleoni M, Gaion F, Liessi G, et al. Medical treatment of hepatocellular carcinoma: any progress? Tumori 1994;80:315-326
26. Falkson G, Moertel C, Lavin P, et al. Chemotherapy studies in primary liver cancer: a prospective randomised clinical trial. Cancer 1978;42:2149-2156
27. Brennan M, Taley R, San Diego E, et al. Critical analysis of 594 cancer patients treated with 5-FU. In: Platner A, ed. Proceedings of the International Symposium on Chemotherapy of Cancer. New York: Elsevier; 1964:118-119
28. Chlebowski R, Brzechwa-Adjukiewicz A, Cowden A, et al. Doxorubicin for HCC: clinical and pharmacokinetic results. Cancer Treat Rep 1984;68:487-491
29. Lai CL, Wu PC, Chan GCB, et al. Doxorubicin versus no anti-tumor therapy in inoperable HCC: a prospective randomised trial. Cancer 1988;62:479-483
30. Broder LE, Carter SK. Pancreatic islet cell carcinoma: results of therapy with streptozotocin in 52 patients. Ann Intern Med 1973;79:108-118
31. Kessinger A, Foley JF, Lemon HM. Therapy of malignant APUD cell tumors: effectiveness of DTIC. Cancer 1983;51:790-794
32. Moertel CG, Johnson CM, McKusick MA, et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994;120:302-309
33. Folprecht G, Grothey A, Alberts S, Raab HR, Kohne CH. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005;16:1311-1319
34. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351:337-345
35. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342
36. McGahan JP, Browning PD, Brock JM, Teslik H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990;25:267-270
37. Rossi P. Radiofrequency ablation of the liver tumours. Paper presented at International Symposium on Endovascular Therapy; Miami Beach, FL; January 23-27, 1999
38. Curley SA, Davidson BS, Fleming RY, et al. Laparoscopically guided bipolar radiofrequency ablation of areas of porcine liver. Surg Endosc 1997;11:729-733
39. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided radiofrequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997;202:195-203
40. Livraghi T, Goldberg SN, Monti F, et al. Saline enhanced radiofrequency tissue ablation in the treatment of liver metastases. Radiology 1997;202:205-210
41. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1-8
42. Jiao LR, Hansen PD, Havlik R, Mitry RR, Pignatelli M, Habib N. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg 1999;177:303-306
43. Lencioni R, Goletti O, Armillotta N, et al. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998;8:1205-1211
44. Marone G, Francica G, D'Angelo V, et al. [Echo-guided radiofrequency percutaneous ablation of hepatocellular carcinoma in cirrhosis using a cooled needle]. Radiol Med (Torino) 1998;95:624-629
45. Francica G, Marone G. Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a cooled tip needle: a preliminary clinical experience. Eur J Ultrasound 1999;9:145-153
46. Kainuma O, Asano T, Aoyama H, et al. Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer. Hepatogastroenterology 1999;46:1071-1077
47. Buscarini L, Buscarini E, Di Stasi M, Quaretti P, Zangrandi A. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med 1999;20:47-53
48. Holtkamp W, Muller W. [Ultrasonically controlled percutaneous high frequency thermotherapy of liver tumours with perfused needle electrodes]. Z Gastroenterol 2000;38:221-227
49. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000;214:761-768
50. Tranberg KG. Percutaneous ablation of liver tumours. Best Pract Res Clin Gastroenterol 2004;18:125-145
51. Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206-1222
52. Adam A. Interventional radiology in the treatment of hepatic metastases. Cancer Treat Rev 2002;28:93-99
53. Lencioni R, Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis 2005;9:301-314
54. Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999;210:655-661
55. Xu KC, Niu LZ, He WB, Guo ZQ, Hu YZ, Zuo JS. Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma. World J Gastroenterol 2003;9:2686-2689
56. Koda M, Murawaki Y, Mitsuda A, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 2001;92:1516-1524
57. Copper IS. Cryogenic surgery: a new method of destruction of extirpation of benign or malignant tissues. N Engl J Med 1963;268:743-749
58. Ravikumar TS, Steele GD Jr. Hepatic cryosurgery. Surg Clin North Am 1989;69:433-440
59. Seifert JK, Morris DL. Indicators of recurrence following cryotherapy for hepatic metastases from colorectal cancer. Br J Surg 1999;86:234-240
60. Ross WB, Horton M, Bertolino P, Morris DL. Cryotherapy of liver tumours: a practical guide. HPB Surg 1995;8:167-173
61. Silverman SG, Sun MRM, Tuncali K, et al. Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. AJR Am J Roentgenol 2004;183:707-712
62. Kuszyk BS, Choti MA, Urban BA, et al. Hepatic tumors treated by cryosurgery: normal CT appearance. AJR Am J Roentgenol 1996;166:363-368
63. Silverman SG, Collick BD, Figueira MR, et al. Interactive MR-guided biopsy in an open-configuration MR imaging system. Radiology 1995;197:175-181
64. Zhou XD, Tang ZY, Yu YQ, et al. The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases. J Cancer Res Clin Oncol 1993;120:100-102
65. Huang A, McCall JM, Weston MD, et al. Phase I study of percutaneous cryotherapy for colorectal liver metastasis. Br J Surg 2002;89:303-310
66. Seifert JK, Junginger Th. Prognostic factors for cryotherapy of colorectal liver metastases. Eur J Surg Oncol 2004;30:34-40
67. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992;216:493-505
68. Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999;23:109-114
69. Ng KK, Lam CM, Poon RT, et al. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model. Ann Surg Oncol 2004;11:650-657
70. Crews KA, Kuhn JA, McCarty TM, et al. Cryosurgical ablation of hepatic tumors. Am J Surg 1997;174:614-617
71. Adam R, Akpinar E, Johann M, et al. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997;225:39-48
72. Zhou XD, Tang ZY. Management of hepatocellular carcinoma: longterm outcome in 2639 cases. Gan To Kagaku Ryoho 1997;24:9-16
73. Zhou XD, Tang ZY, Yu YQ, et al. Clinical evaluation of cryosurgery in the treatment of primary liver cancer: report of 60 cases. Cancer 1988;61:1889-1892
74. Wong WS, Patel SC, Cruz FS, et al. Cryosurgery as a treatment for advanced-stage hepatocellular carcinoma: results, complications, and alcohol ablation. Cancer 1998;82:1268-1278
75. Cha C, Lee FT, Rikkers LF, et al. Rationale for the combination of cryoablation with surgical resection of hepatic tumors. J Gastrointest Surg 2001;5:206-213
76. Bilchik AJ, Wood TF, Allefra DP, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms. Arch Surg 2000;135:657-664
77. Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998;228:201-208
78. Mala T, Edwin B, Mathisen O, et al. Cryoablation of colorectal liver metastases: minimally invasive tumour control. Scand J Gastroenterol 2004;39:571-578
79. Cozzi PJ, Englund R, Morris DL. Cryotherapy treatment of patients with hepatic metastases from neuroendocrine tumors. Cancer 1995;76:501-509
80. Seifert JK, Cozzi PJ, Morris DL. Cryotherapy for neuroendocrine liver metastases. Semin Surg Oncol 1998;14:175-183
81. Shapiro RS, Shafir M, Sung M, Warner R, Glajchen N. Cryotherapy of metastatic carcinoid tumors. Abdom Imaging 1998;23:314-317